Loading comparison data...
Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare Metformin (Glucophage) and Sitagliptin (Januvia) — clinical data, side effects, and patient experiences.
Glucophage, Fortamet, Glumetza · Biguanide
How it works
Decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.
Approved for
Januvia, ZITUVIMET · DPP-4 Inhibitor
How it works
Inhibits dipeptidyl peptidase-4 (DPP-4) enzyme, slowing the inactivation of incretin hormones GLP-1 and GIP, thereby increasing insulin release and decreasing glucagon levels in a ...
Approved for
Estimated frequency (%) based on clinical trial data
Based on 30 Reddit discussions
Metformin
27%
positive
15 threads
Sitagliptin
40%
positive
15 threads
% of discussions mentioning each side effect
Based on 2 verified patient reviews
No data yet
No data yet
Avg. Duration
24 months
100% still taking
Avg. Duration
18 months
100% still taking
Metformin is a Biguanide, while Sitagliptin belongs to the DPP-4 Inhibitor class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles. Metformin has a half-life of 6.2 hours, compared to 12.4 hours for Sitagliptin. A longer half-life may allow for less frequent dosing but can also mean side effects persist longer.
Both medications are approved for Type 2 Diabetes Mellitus. When two drugs treat the same condition, the choice between them often depends on the patient's medical history, other medications, tolerability, and prescriber preference.
Metformin has an average efficacy rating of 8.0/10 and tolerability of 6.0/10 across 1 patient review. Sitagliptin has an average efficacy rating of 7.0/10 and tolerability of 9.0/10 across 1 patient review. Patient-reported outcomes provide real-world context beyond clinical trials, though individual responses to medication vary significantly..
Metformin carries 2 FDA warnings. Sitagliptin carries 2 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
There is 1 clinical study directly comparing Metformin and Sitagliptin. Head-to-head trial data provides the strongest evidence for comparative effectiveness, though study design, endpoints, and patient populations should be considered when interpreting results.
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.